Farrerol inhibits IL-6 and IL-8 production in LPS-stimulated human gingival fibroblasts by suppressing PI3K/AKT/NF-kappa B signaling pathway

作者

Wang, Q;Zhang, B;Yu, JL

作者单位

[Wang, Qian] Shandong Univ, Shandong Prov Hosp, Dept Pharm, Jinan 250000, Shandong, Peoples R China.;-;[Zhang, Bin; Yu, Jin-Long] Shandong Univ, Hosp 2, Dept Pharm, Jinan 250000, Shandong, Peoples R China.

摘要

Objectives: Farrerol, a new type of 2,3-dihydro-flavonoid isolated from rhododendron, has been shown to have anti-bacterial and anti-inflammatory activities. In the present study, we investigated the anti-inflammatory effects of farrerol on the production of IL-6 and IL-8 in human gingival fibroblasts (HGFs) treated with lipopolysaccharide (LPS).;-;Methods: The cytotoxicity of farrerol was determined using the MTT assay. The production of IL-6 and IL-8 was measured using ELISA and qRT-PCR. The effects of farrerol on PI3K, Akt phosphorylation, and NF-kappa B activation were detected using western blotting analyses.;-;Results: These results showed that farrerol inhibited LPS-induced IL-6 and IL-8 production in a dose dependent manner. LPS-induced NF-kappa B activation was suppressed by farrerol. Furthermore, farrerol suppressed LPS-induced PI3K and Akt phosphorylation, which are upstream molecules of NF-kappa B.;-;Conclusion: These results indicated that farrerol attenuated IL-6 and IL-8 production by inhibition of PI3K and AKT phosphorylation, resulting in an inhibition of NF-kappa B activation. Farrerol may be a therapeutic agent for the treatment of periodontal disease. (C) 2015 Elsevier Ltd. All rights reserved.

关键词

NF-KAPPA-B; PORPHYROMONAS-GINGIVALIS; PERIODONTAL-DISEASE; EPITHELIAL-CELLS; EXPRESSION; LIPOPOLYSACCHARIDE; MEDIATORS; RESPONSES

基本信息

所属机构:西药房

归属医师: 王倩

PMID：26615574

UT：000384514100004

刊名:ARCHIVES OF ORAL BIOLOGY

年，卷(期):2016年62卷

页码：28-32

DOI：10.1016/j.archoralbio.2015.11.007

附件：

收录: SCIE